Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation
Schneider Gasser, E.M.
KeywordCancer anaemia; Recombinant erythropoietin; Erythropoietin receptor; Antibody; Risk assessment
Rights© 2014 Wiley This is the peer reviewed version of the following article: Maxwell P, Melendez-Rodriguez F, Matchett KB et al. (2015) Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. British Journal of Haematology. 168: 429-442, which has been published in final form at http://dx.doi.org/10.1111/bjh.13133 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.